← All Articles

CUBEC Editorial

Canada: We Must Act Now to Bolster our Biomedical Sector

CUBEC Editorial Team

April 24, 2025

Since early February, updates surrounding the American National Institute of Health (NIH) under the Trump administration have caused a whirlwind of fear and uncertainty over the future of biomedical research in the United States. On February 7, 2025, the NIH updated its policy to place a 15% indirect cost rate on all new and existing awards. These rates are typically negotiated between the university and the NIH based on research expenses, and can regularly exceed 50% for select top schools, making the renewed 15% deal a devastating figure for thousands of labs that depend on higher rates to maintain their operations [1]. Since it was announced, over 20 state Attorneys General filed lawsuits against the policy, and although a federal judge blocked the move across the country [2], fears over whether or not scientists can sustain their research are mounting.

The American National Science Foundation (NSF), which also issues grants to science and engineering researchers and institutions across the United States, has similarly seen drastic changes in how it awards funding. The NSF has allegedly added 108 restricted keywords that will result in greater scrutiny to grant applications, including 'female', 'excluded', 'biases', 'polarization', and 'diversify' [3]. The institution has awarded 50% fewer grants since the change in administration than in previous years [4]. Funding to states has also been targeted, with the administration moving to cut over $11 billion in public health research across the country, impacting tracking and management, vaccine access, mental health support, and healthcare infrastructure. 23 states and the District of Columbia moved to keep funding intact [5].

New leadership and restructuring within health agencies have particularly disturbed the scientific community. Robert F. Kennedy Jr., who ran for president as a democrat before switching to an independent bid, was controversially made Secretary of Health and Human Services (HHS). Principally known for his anti-vaccine rhetoric, his comments have been linked to the 2019 Samoa measles outbreak where 5700 people were infected and 83 people died [6], cited by the Samoa Ministry of Health for promoting vaccine hesitancy during his visit. In addition, two new appointees were recently placed to lead the NIH and FDA respectively, and both have publicly advocated for achieving population-wide herd immunity through mass infection as a way to accelerate protection, a strategy which has faced extensive criticism [7]. Mass layoffs throughout the federal government have particularly impacted health agencies, with 1200 reported at the NIH, 700 at the FDA, and 1300 at the CDC in the past couple months alone [8, 9, 10].

The combined effects of policies and leadership implemented in this period have been absolutely devastating for the American scientific community, and the impacts will be felt for years to come. Biomedical and public health research is not trivial — it's absolutely vital to the public well-being, to national prosperity, and to the success of the private sector. From 2010 to 2016, NIH funding contributed to 100% of new drug development, with over 90% of public funding representing basic science research [11]. It's estimated that for every dollar spent by the NIH, $2.56 is delivered into the American economy, substantiating the agency's role and impact on the country [12]. It's for this reason that many countries are positioning themselves to attract top American talent. The engineering school of CentraleSupélec in France recently announced they will allocate $3.2 million USD to finance discontinued American research projects, while Aix-Marseille University launched its 'Safe Place for Science' program, offering researchers an employment contract and research budget for up to three years, with additional relocation assistance [13,14].

While these pillars of American science are dismantled, another target of interest has also been defined: Canada. Since the change in administration, there has been a clear intention to apply economic pressure on Canada. On March 4, the US imposed 25% tariffs on Canadian goods, with a 10% tariff for energy and potash exports; on March 12, they imposed 25% tariffs on steel and aluminum; and on April 3, they imposed 25% tariffs on Canadian automobiles and intended to extend this to certain car parts by May 3 [15]. While across-the-board tariffs have been on-again-off-again, the economic situation across the country remains dire. In response, Canada has imposed retaliatory tariffs of 25% on $30 billion (USD) worth of American imports and intends to match American tariffs on steel and aluminum dollar-for-dollar [15].

Although these counter-measures have been drafted thoughtfully, the Canadian response has been far too lackluster in the face of these pressures.

We are not witnessing a momentary economic shake-up, but a fundamental, seismic shift in the relationship between our two countries. In this new context, Canada must use every tool at its disposal to defend its sovereignty and future. Therefore, while the floundering of American biomedical science is deeply saddening, it poses a unique opportunity Canada can leverage for its long-term national and economic security. Canada must act by partnering with its universities to extract top American biomedical talent by boosting research funding and by launching national incentive programs to draw researchers north.

Of more than 1600 respondents to a Nature poll asking researchers if they were contemplating leaving the country, over 75% said yes. This was pronounced among young researchers, where 548 of 690 postgraduate researchers and 255 of 340 PhD students said they were considering moving. When asked where they would move to, respondents were interested in countries where they had collaborators, friends, family, and familiarity with the local language [16].

Thankfully, Canada assumes a natural advantage over other countries due to its relationship, proximity, and shared culture and language with many Americans. Such a move by Canada could also reverse scientific emigration to the United States. While most all graduate students are grossly underpaid, as it stands, American stipends tend to be much higher than Canadian ones; Nature reports that the highest Canadian stipend is equivalent to the lowest biology stipend in the United States [17].

While the Canadian government is not flush with cash by any means, our geopolitical situation necessitates bold moves that ensure national security and long-term strategic advantage. For too long, Canada has been complaisant in entrusting its biomedical needs with American research and American private industry, and now that its public funding is facing crisis, we must act decisively to attract its talent to our own institutions. If carried out successfully, our return on investment could be exponential in terms of its reach and impact for the health outcome of millions of Canadians. In this way, we can pioneer a future for biomedical science and engineering that is uniquely, and proudly, Canadian.

References

[1] "Science under siege: Trump cuts threaten to undermine decades of research," NBCNews.com.
[2] C. Villalonga-Vivoni, Connecticut medical researchers, patients and families "terrified" as NIH cuts are proposed, CT Insider.
[3] L. Stone, "Forbidden words and funding freezes: What we know about Trump's changes to federal grant funding," Graziani Multimedia.
[4] J. Mervis, NSF has awarded almost 50% fewer grants since Trump took office, Science/AAAS.
[5] J. Rosen and A. Tin, "Federal judge temporarily blocks $11 billion in Trump administration's cuts to public health funding," CBS News.
[6] Y. T. Yang, "The perils of RFK Junior's anti-vaccine leadership for Public Health," The Lancet, vol. 405, no. 10473, p. 122, Jan. 2025.
[7] "Senate confirms Marty Makary to lead FDA, Jay Bhattacharya to head NIH," CBS News.
[8] J. Kaiser, "More NIH job cuts coming? Agency's scientists already reeling after week of firings," Science/AAAS.
[9] M. Perrone, "FDA moves to rehire medical device, food safety and other staffers fired days earlier," AP News.
[10] A. Picchi, "Federal Workers Express Shock, anger over mass firings," CBS News.
[11] E. Galkina Cleary, J. M. Beierlein, N. S. Khanuja, L. M. McNamee, and F. D. Ledley, "Contribution of NIH funding to New Drug Approvals 2010–2016," Proceedings of the National Academy of Sciences, vol. 115, no. 10, pp. 2329–2334, Feb. 2018.
[12] S. Boles, "NIH funding delivers exponential economic returns," Harvard Gazette.
[13] C. Duster, "Countries boost recruitment of American scientists amid cuts to scientific funding," NPR.
[14] D. Robinson, "France offers to take in US scientists," The Register.
[15] "Canada announces new countermeasures in response to tariffs from the United States of America," Prime Minister of Canada.
[16] A. Witze, "75% of US scientists who answered nature poll consider leaving," Nature News.
[17] B. Owens, "Graduate-student stipends in Canada below the poverty line," Nature News.